Primecap Management CO Bio N Tech Se Transaction History
Primecap Management CO
- $132 Billion
- Q1 2024
A detailed history of Primecap Management CO transactions in Bio N Tech Se stock. As of the latest transaction made, Primecap Management CO holds 4,807,918 shares of BNTX stock, worth $386 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
4,807,918
Previous 4,763,453
0.93%
Holding current value
$386 Million
Previous $503 Million
11.78%
% of portfolio
0.34%
Previous 0.4%
Shares
18 transactions
Others Institutions Holding BNTX
# of Institutions
326Shares Held
40.4MCall Options Held
1.31MPut Options Held
1.37M-
Baillie Gifford & CO8.36MShares$672 Million0.61% of portfolio
-
Harding Loevner LP Bridgewater, NJ3.82MShares$307 Million2.24% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M3.47MShares$279 Million1.4% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U03.43MShares$276 Million1.76% of portfolio
-
Black Rock Inc. New York, NY1.91MShares$153 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $19.5B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...